ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
127.67
-0.73
(-0.57%)
Closed November 12 4:00PM
127.67
0.00
( 0.00% )
Pre Market: 4:05AM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
127.67
Bid
112.00
Ask
172.60
Volume
1
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
Previous Close
127.67
Open
-
Last Trade
1
@
127.67
Last Trade Time
04:12:42
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
56,614,385
Dividend Yield
-
PE Ratio
0.00
Earnings Per Share (EPS)
-
Revenue
200.64M
Net Profit
-481.45M

About Ascendis Pharma AS

Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and ... Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Hellerup, Dnk
Founded
-
Ascendis Pharma AS is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ASND. The last closing price for Ascendis Pharma AS was $127.67. Over the last year, Ascendis Pharma AS shares have traded in a share price range of $ 0.00 to $ 0.00.

Ascendis Pharma AS currently has 56,614,385 shares outstanding. The market capitalization of Ascendis Pharma AS is $7.23 billion.

ASND Latest News

Ascendis Pharma to Report Third Quarter 2024 Financial Results and Provide Business Update on November 14, 2024

COPENHAGEN, Denmark, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced it will report third quarter 2024 financial results and provide a business update on...

Ascendis Pharma and Novo Nordisk Sign Collaboration for Development and Commercialization of TransCon Technology-based Products in Metabolic and Cardiovascular Diseases

-  Collaboration leverages Ascendis’ proprietary TransCon™ technologies and Novo Nordisk’s expertise in cardiometabolic diseases -  Once-monthly GLP-1 receptor agonist will be the collaboration’s...

Ascendis Pharma Announces Submission of Supplemental Biologics License Application to FDA for TransCon™ hGH for the Treatment of Adults with Growth Hormone Deficiency

COPENHAGEN, Denmark, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced it has submitted a supplemental Biologics License Application (sBLA) to the U.S. Food...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MVSTMicrovast Holdings Inc
$ 0.3652
(102.10%)
6.36M
NMHINatures Miracle Holding Inc
$ 0.1305
(52.28%)
14.85M
DAVEDave Inc
$ 88.28
(40.57%)
2.58k
CYCCCyclacel Pharmaceuticals Inc
$ 0.5608
(36.78%)
1.36M
RKLBRocket Lab USA Inc
$ 18.64
(27.15%)
459.23k
SYRSSyros Pharmaceuticals Inc
$ 0.5244
(-80.79%)
1.62M
SIDUSidus Space Inc
$ 1.24
(-44.89%)
158.43k
VRMVroom Inc
$ 5.98
(-32.58%)
2.78k
NANano Labs Ltd
$ 5.35
(-30.52%)
8.07k
SGMOSangamo Therapeutics Inc
$ 2.09
(-22.88%)
58.79k
NMHINatures Miracle Holding Inc
$ 0.1305
(52.28%)
14.85M
MVSTMicrovast Holdings Inc
$ 0.3652
(102.10%)
6.36M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 20.73
(5.18%)
3.07M
SYRSSyros Pharmaceuticals Inc
$ 0.5244
(-80.79%)
1.62M
TSLZT Rex 2X Inverse Tesla Daily Target ETF
$ 4.25
(-5.13%)
1.37M

Discussion

View Full Feed
No Posts Found

Your Recent History

Delayed Upgrade Clock